This program happened in the past, and no dates are currently scheduled.Select this button to navigate the sections of this page
This program is designed to bring information learned at national meetings back to the central Pennsylvania area for physicians and other health care professionals to use in their daily clinical practices. The topics chosen represent material presented at the 2019 American Society of Hematology (ASH) National Meeting and the 2019 San Antonio Breast Cancer Symposium (SABCS).
This activity is not endorsed by or affiliated with SABCS or ASH.
- Present the latest scientific information from the national meetings.
- Review treatment and research findings.
- Assess implications for clinical practice.
- 7:30 a.m. | Check-In/Breakfast/Visit Exhibitors
- 7:55 a.m. | Introduction and Welcome
Harold A. Harvey, MD
- 8 a.m. | Updates in Recent Improvements in the Management of Lymphomas
Seema Naik, MD
- 8:35 a.m. | Review New Treatment Approaches for Multiple Myeloma
Kevin L. Rakszawski, MD
- 9:10 a.m. | Break/Visit Exhibitors
- 9:35 a.m. | Discuss Current Biology and Management of Leukemias
Hong Zheng, MD, PhD
- 10:10 a.m. | Review Stem Cell Biology and Aging as Precursors of Leukemia
Witold B. Rybka, MD, FRCPC
- 10:45 a.m. | Appreciate New Hope in Sickle Cell Disease Outcomes
Elizabeth H. Federici, MD
- 11:20 a.m. | Discuss the Role of Thrombosis in Cancer
Ricardo Carter, MD
- 11:55 a.m. | Lunch/Visit Exhibitors
- 12:55 p.m. | Update on Myeloproliferative Neoplasms
Natthapol Songdej, MD, MPH
- 1:30 p.m. | Update on High-Risk Breast Cancer Evaluation and Work-Up
Daleela G. Dodge, MD
- 2:05 p.m. | Break/Visit Exhibitors
- 2:15 p.m. | Discuss Duration of Adjuvant Endocrine Therapy
Harold A. Harvey, MD
- 2:50 p.m. | Review of New Drugs and Regimens in Early and Late Breast Cancer
Cristina I. Truica, MD
- 3:25 p.m. | Explain Role of Biomarkers in Targeted Therapy of Breast Cancer
Kim Leitzel, MA
- 4 p.m. | Adjournment
Penn State College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Penn State College of Medicine designates this live activity for a maximum of 6.5 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses Using AMA Credit
Nurses will receive a certificate from Penn State College of Medicine verifying their participation in 6.5 hours of approved continuing medical education. Continuing education activities which are approved by accredited institutions of higher education and that are relevant to patient care or professional nursing meet the requirements of mandatory continuing education for registered nurses in Pennsylvania, as required by the Pennsylvania State Board of Nursing. The Board of Nursing recommends that nurses retain their certificates for a period of at least five years. Additional information is available through the State Board of Nursing website.
Fee is $60 per person and includes cost of instruction, online handout materials and all listed meals.
Registrations received after March 5, 2020, will incur a $25 late fee.
Cancellations received after Feb. 28, 2020, will be assessed a $25 processing fee.
No refunds will be made for cancellations that are received after March 3, 2020.
The University reserves the right to cancel or postpone any course or activity because of insufficient enrollment or other unforeseen circumstances. If a program is canceled or postponed, the University will refund registration fees but cannot be held responsible for any related costs, charges, or expenses, including cancellation/change charges assessed by airlines or travel agencies. Preregistered participants will be notified if a program is filled or canceled.
Penn State encourages persons with disabilities to participate in its programs and activities. If you anticipate needing any type of special accommodation or have questions about the physical access provided, please contact Continuing Education at least one week in advance of your participation or visit.
Content and speakers for all programs are subject to change. Registrants will be notified of any significant updates.
Disclosure and Conflict of Interest (COI and educational balance)
It is our policy to ensure balance, independence, objectivity, and scientific rigor in all of our educational programs. Faculty and course directors have disclosed relevant financial relationships with commercial companies, and Penn State has a process in place to resolve any conflict of interest. Complete faculty disclosure will be provided to program participants at the beginning of the activity.
University Nondiscrimination Policy
This publication is available in alternative media on request. The Pennsylvania State University is committed to the policy that all persons shall have equal access to programs, facilities, admission, and employment without regard to personal characteristics not related to ability, performance, or qualifications as determined by University policy or by state or federal authorities. It is the policy of the University to maintain an academic and work environment free of discrimination, including harassment. The Pennsylvania State University prohibits discrimination and harassment against any person because of age, ancestry, color, disability or handicap, genetic information, national origin, race, religious creed, sex, sexual orientation, gender identity, or veteran status and retaliation due to the reporting of discrimination or harassment. Discrimination, harassment, or retaliation against faculty, staff, or students will not be tolerated at The Pennsylvania State University. Direct all inquiries regarding the Nondiscrimination Policy to the Affirmative Action Director, The Pennsylvania State University, 328 Boucke Building, University Park, PA 16802-5901; tel 814-863-0471/TTY. US M.Ed. J6543